About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Bionic Pancreas Successfully Tested in Adults and Adolescents

by Kathy Jones on June 16, 2014 at 10:33 PM
Font : A-A+

 Bionic Pancreas Successfully Tested in Adults and Adolescents

American researchers have successfully tested a bionic pancreas device, which imposes minimal restrictions on patient activities, in both adult and adolescents.

A team of investigators from Boston University (BU) and Massachusetts General Hospital (MGH) report study results in a New England Journal of Medicine paper being issued online to coincide with a presentation (abstract # 237-OR) at the American Diabetes Association Scientific Sessions. The device controls blood sugar in patients with type 1 diabetes using doses of both insulin and the blood-sugar-raising hormone glucagon.

Advertisement

"In both of these studies this device far exceeded our expectations in terms of its ability to regulate glucose, prevent hypoglycemia and automatically adapt to the very different needs of adults - some of whom were very insulin-sensitive - and adolescents, who typically need higher insulin doses," says Edward Damiano, PhD, of the BU Department of Biomedical Engineering, principal investigator of the project and senior author of the NEJM report. "There's no current standard-of-care therapy that could match the results we saw."

Firas El-Khatib, PhD, of the BU Department of Biomedical Engineering, adds, "One of the key virtues of this device is its ability to start controlling the blood sugar instantly, based only on the patient's weight, and continually adapt its decision making regarding insulin and glucagon dosing to handle a wide range of dosing requirements." El-Khatib co-designed the bionic pancreas device with Damiano and is co-lead author of the NEJM report with Steven Russell, MD, PhD, of the MGH Diabetes Unit,.
Advertisement

Russell - who led the clinical trials reported in the current paper - Damiano, and El-Khatib previously published a 2010 Science Translational Medicine report that described successful use of the first-generation system in controlling the blood sugar of adults for 27 hours. But that study took place in a controlled hospital inpatient environment where participants essentially stayed in bed for the whole period and ate prescribed meals. "The key element with the current version of this device is that it's wearable, allowing participants to stay in something close to their usual environments, exercise and eat whatever they want," says Russell.

Additional inpatient trials conducted after the 2010 paper extended the study period to two days and included adolescents as well as adults. But developing a device that could be tested safely in an outpatient environment presented several challenges, first among which was a control system that could adapt not only to the minute-by-minute changing needs of an individual, but also to the very different needs of adults and adolescents. The rapid growth and hormonal changes of adolescence produces insulin requirements that are two to three times greater than those of adults of the same body weight, Damiano explains. And even though the dosage needs of adults are more predictable, contracting typical a illness like a cold or upset stomach can dramatically change the need for insulin over a period of days to weeks.



Source: Eurekalert
Advertisement

Advertisement
Advertisement

Recommended Reading

Latest Diabetes News

How to Recognize the Signs of Unrecognized Cardiovascular Disease in Type 2 Diabetes?
In type 2 diabetes individuals, regular screening for two key cardiac biomarkers may decrease the risk of cardiovascular disease events.
 FDA Approves “Bionic Pancreas” For Type 1 Diabetes Management
The US Food and Drug Administration (FDA) clears the 'bionic pancreas' that improves the management of type 1 diabetes, without the need for constant blood sugar testing.
 1 In 5 “Healthy” People Actually Have Slightly Higher Blood Sugar Level
A new study investigated the use of a mathematical model of glucose metabolism to assess continuous glucose monitor data as a metric of dysfunctional glycemic control.
400 Medicinal Plants: Uncovering Their Anti-Diabetic Properties
At least 400 medicinal plants effective in decreasing sugar levels in the blood which is critical to control type 2 diabetes identified.
World's First Oral Insulin for Type-2 Diabetes
Considering the enormous type 2 diabetes patient population in China, a new oral insulin therapy will improve treatment.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Bionic Pancreas Successfully Tested in Adults and Adolescents Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests